Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06362993

Breast Cancer Screening in Ghana

This study is designed to test the feasibility of two intervention on promoting early screening for breast cancer in rural Ghana. In one intervention, screening for breast cancer, diabetes and hypertension will be offered together. In another intervention, a series of sessions with men will be conducted with a goal to change gender attitudes and increase support to women. The investigators' long-term goal is to test these interventions in a large-scale randomized controlled trial. The specific aims of this feasibility study are to: 1) refine the study materials, including the curriculum for the sessions with men, by consulting with an expert advisory committee and a local committee, and 2) determine the feasibility of the two interventions in four clinic zones in Yilo-Krobo district in eastern Ghana (1 clinic in control, 1 clinic in the first intervention, and 2 in the second intervention). This trial registration is for the second specific aim.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Breast Cancer Female

Age range

20 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Ghana

Accra, Ghana

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥20 years. The age cutoff reflects early onset of BC in Ghana and the government's guidelines on screening.

Exclusion criteria

  • ever clinically diagnosed with a case of breast cancer, as the study's aim is to reach women who would normally not visit or have experience with the health system with regard to breast cancer.

NOTE: For men in the MEGH arm, Inclusion and Exclusion Criteria are:

Inclusion criteria

aged ≥20 years who are identified as male partners or relatives by the women enrolled in the MEGH group.

Exclusion criteria

none.

Treatment and study plan

Bundling

Other

Education on and screening for diabetes and hypertension offered together with education and screening for breast cancer.

MEGH

Other

Education on breast cancer and discussion sessions to male partners to change men's gender attitudes and behaviors.

Primary outcomes

  1. Clinical breast exam (CBE) utilization at the local clinic

    Time frame: 6 months. Outcome is measured at endline survey at the end of the 6-month period.

    The outcome will be measured by asking participants, at endline, if they sought clinical breast exam at their local clinic during the 6-month study period. This information will be verified at the clinic level using Participation Cards, which will be provided to participants at the beginning of the 6-month period. Participants will be asked to bring the Card to the clinic when they come for screening.

Sponsors and collaborators

Lead sponsor

Penn State University

Other

Collaborators

  • University of Ghana

Registry information

Official study title

Testing Approaches to Promote Breast Cancer Screening in Rural Ghana

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Apr 12, 2024
Registry last updated
Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.